Studies in non-diabetic participants with obesity using surrogate indices of insulin sensitivity have found that the VLCD resulted in significantly lower insulin resistance as measured by HOMA-IR [27–30] and improvement in insulin sensitivity using the QUICKI [31]. The gene discussed is INS; the disease is obesity disorder.